<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://mutage.oxfordjournals.org">
<title>Mutagenesis - recent issues</title>
<link>http://mutage.oxfordjournals.org</link>
<description>Mutagenesis - RSS feed of recent issues (covers the latest 3 issues, including the current issue) </description>
<prism:eIssn>1464-3804</prism:eIssn>
<prism:publicationName>Mutagenesis</prism:publicationName>
<prism:issn>0267-8357</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://mutage.oxfordjournals.org/cgi/content/short/23/3/143?rss=1" />
  <rdf:li rdf:resource="http://mutage.oxfordjournals.org/cgi/content/short/23/3/153?rss=1" />
  <rdf:li rdf:resource="http://mutage.oxfordjournals.org/cgi/content/short/23/3/163?rss=1" />
  <rdf:li rdf:resource="http://mutage.oxfordjournals.org/cgi/content/short/23/3/171?rss=1" />
  <rdf:li rdf:resource="http://mutage.oxfordjournals.org/cgi/content/short/23/3/183?rss=1" />
  <rdf:li rdf:resource="http://mutage.oxfordjournals.org/cgi/content/short/23/3/191?rss=1" />
  <rdf:li rdf:resource="http://mutage.oxfordjournals.org/cgi/content/short/23/3/207?rss=1" />
  <rdf:li rdf:resource="http://mutage.oxfordjournals.org/cgi/content/short/23/3/223?rss=1" />
  <rdf:li rdf:resource="http://mutage.oxfordjournals.org/cgi/content/short/23/3/233?rss=1" />
  <rdf:li rdf:resource="http://mutage.oxfordjournals.org/cgi/content/short/23/2/77?rss=1" />
  <rdf:li rdf:resource="http://mutage.oxfordjournals.org/cgi/content/short/23/2/87?rss=1" />
  <rdf:li rdf:resource="http://mutage.oxfordjournals.org/cgi/content/short/23/2/93?rss=1" />
  <rdf:li rdf:resource="http://mutage.oxfordjournals.org/cgi/content/short/23/2/101?rss=1" />
  <rdf:li rdf:resource="http://mutage.oxfordjournals.org/cgi/content/short/23/2/111?rss=1" />
  <rdf:li rdf:resource="http://mutage.oxfordjournals.org/cgi/content/short/23/2/119?rss=1" />
  <rdf:li rdf:resource="http://mutage.oxfordjournals.org/cgi/content/short/23/2/131?rss=1" />
  <rdf:li rdf:resource="http://mutage.oxfordjournals.org/cgi/content/short/23/2/137?rss=1" />
  <rdf:li rdf:resource="http://mutage.oxfordjournals.org/cgi/content/short/23/1/1?rss=1" />
  <rdf:li rdf:resource="http://mutage.oxfordjournals.org/cgi/content/short/23/1/19?rss=1" />
  <rdf:li rdf:resource="http://mutage.oxfordjournals.org/cgi/content/short/23/1/27?rss=1" />
  <rdf:li rdf:resource="http://mutage.oxfordjournals.org/cgi/content/short/23/1/35?rss=1" />
  <rdf:li rdf:resource="http://mutage.oxfordjournals.org/cgi/content/short/23/1/43?rss=1" />
  <rdf:li rdf:resource="http://mutage.oxfordjournals.org/cgi/content/short/23/1/51?rss=1" />
  <rdf:li rdf:resource="http://mutage.oxfordjournals.org/cgi/content/short/23/1/57?rss=1" />
  <rdf:li rdf:resource="http://mutage.oxfordjournals.org/cgi/content/short/23/1/67?rss=1" />
  <rdf:li rdf:resource="http://mutage.oxfordjournals.org/cgi/content/short/23/1/75?rss=1" />
 </rdf:Seq>
</items>
</channel>

<item rdf:about="http://mutage.oxfordjournals.org/cgi/content/short/23/3/143?rss=1">
<title><![CDATA[The comet assay: topical issues]]></title>
<link>http://mutage.oxfordjournals.org/cgi/content/short/23/3/143?rss=1</link>
<description><![CDATA[
<p>The comet assay is a versatile and sensitive method for measuring single- and double-strand breaks in DNA. The mechanism of formation of comets (under neutral or alkaline conditions) is best understood by analogy with nucleoids, in which relaxation of DNA supercoiling in a structural loop of DNA by a single DNA break releases that loop to extend into a halo&mdash;or, in the case of the comet assay, to be pulled towards the anode under the electrophoretic field. A consideration of the simple physics underlying electrophoresis leads to a better understanding of the assay. The sensitivity of the assay is only fully appreciated when it is calibrated: between one hundred and several thousand breaks per cell can be determined. By including lesion-specific enzymes in the assay, its range and sensitivity are greatly increased, but it is important to bear in mind that their specificity is not absolute. Different approaches to quantitation of the comet assay are discussed. Arguments are presented against trying to apply the comet assay to the study of apoptosis. Finally, some of the advantages and disadvantages of using the comet assay on lymphocyte samples collected in human studies are rehearsed.</p>
]]></description>
<dc:creator><![CDATA[Collins, A. R., Oscoz, A. A., Brunborg, G., Gaivao, I., Giovannelli, L., Kruszewski, M., Smith, C. C., Stetina, R.]]></dc:creator>
<dc:date>2008-05-02</dc:date>
<dc:identifier>info:doi/10.1093/mutage/gem051</dc:identifier>
<dc:title><![CDATA[The comet assay: topical issues]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>151</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>143</prism:startingPage>
<prism:section>REVIEWS</prism:section>
</item>

<item rdf:about="http://mutage.oxfordjournals.org/cgi/content/short/23/3/153?rss=1">
<title><![CDATA[The use of the comet assay in the study of human nutrition and cancer]]></title>
<link>http://mutage.oxfordjournals.org/cgi/content/short/23/3/153?rss=1</link>
<description><![CDATA[
<p>The influence of diet on carcinogenesis is a hugely complex area; not only is the consumption of major dietary factors such as meat, fat and fruits and vegetables associated with increased or decreased risk of a range of cancers but also an increasing number of specific nutrients such as vitamins, minerals and phytochemicals are being proposed as the next &lsquo;superfoods&rsquo; to combat the development of cancer. As well as epidemiological studies to determine the association of these dietary factors with cancer risk, it is also essential to investigate the underlying mechanisms through which these factors may causally influence carcinogenesis. The comet assay provides a relatively simple, cheap and rapid method to examine DNA damage and repair and is, therefore, an ideal biomarker for the study of the effects of nutrition on cancer. This review focuses on the use of the comet assay in studies involving human subjects or human cell lines, which investigate the effects of various nutrients on biomarkers relevant to carcinogenesis, and discusses the potential of the comet assay and its various modifications for use as cancer-related biomarkers suitable for use in nutritional studies.</p>
]]></description>
<dc:creator><![CDATA[Wasson, G. R., McKelvey-Martin, V. J., Downes, C. S.]]></dc:creator>
<dc:date>2008-05-02</dc:date>
<dc:identifier>info:doi/10.1093/mutage/gen003</dc:identifier>
<dc:title><![CDATA[The use of the comet assay in the study of human nutrition and cancer]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>162</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>153</prism:startingPage>
<prism:section>REVIEWS</prism:section>
</item>

<item rdf:about="http://mutage.oxfordjournals.org/cgi/content/short/23/3/163?rss=1">
<title><![CDATA[Using the alkaline comet assay in prognostic tests for male infertility and assisted reproductive technology outcomes]]></title>
<link>http://mutage.oxfordjournals.org/cgi/content/short/23/3/163?rss=1</link>
<description><![CDATA[
<p>Infertility affects one in six couples in Europe during their reproductive years with dysfunctional sperm being one of the most common causes. Conventional semen analysis has proven variable and lacking in prognostic value so, over the past decade, more useful molecular fertility biomarkers have been explored. Among the tests showing most promise are those measuring sperm DNA quality. Sperm DNA damage has been closely associated with numerous indicators of reproductive health, including, fertilization, embryo quality, implantation, spontaneous abortion and childhood diseases. It therefore has great potential as a prognostic test for assisted reproductive treatment (ART), when couples are presenting with male infertility. Unlike somatic cells, sperm have a unique tightly compacted chromatin structure. Our group has modified the alkaline comet assay for use with sperm. Sperm DNA also differs from somatic cells in its high susceptibility to oxidative damage; this is largely due to the presence of abundant polyunsaturated fatty acids acting as substrates for reactive oxygen species (ROS) and its lack of repair mechanisms. Consequently, the effects of ROS and antioxidant protection on sperm DNA fragmentation have been widely investigated. In this review, the relationship between actual sperm DNA damage as determined by the alkaline comet assay and potential DNA damage as measured by DNA adduct testing will also be examined and the potential of routine clinical practices such as cryopreservation and prolonged incubation to induce further DNA damage was investigated. Finally, the usefulness of sperm DNA tests as prognostic markers and in particular, the opportunities and challenges provided by DNA testing in male fertility determination will be discussed.</p>
]]></description>
<dc:creator><![CDATA[Lewis, S. E. M., Agbaje, I. M.]]></dc:creator>
<dc:date>2008-05-02</dc:date>
<dc:identifier>info:doi/10.1093/mutage/gem052</dc:identifier>
<dc:title><![CDATA[Using the alkaline comet assay in prognostic tests for male infertility and assisted reproductive technology outcomes]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>170</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>163</prism:startingPage>
<prism:section>REVIEWS</prism:section>
</item>

<item rdf:about="http://mutage.oxfordjournals.org/cgi/content/short/23/3/171?rss=1">
<title><![CDATA[Statistical issues in the use of the comet assay]]></title>
<link>http://mutage.oxfordjournals.org/cgi/content/short/23/3/171?rss=1</link>
<description><![CDATA[
<p>The comet or single-cell gel electrophoresis assay is now widely used in regulatory, mechanistic and biomonitoring studies using a range of <I>in vitro</I> and <I>in vivo</I> systems. Each of these has issues associated with the experimental design which determine to a large extent the statistical analyses than can be used. A key concept is that the experimental unit is the smallest &lsquo;amount&rsquo; of experimental material that can be randomly assigned to a treatment: the animal for <I>in vivo</I> studies and the culture for <I>in vitro</I> studies. Biomonitoring studies, being observational rather than experimental, are vulnerable to confounding and biases. Critical factors in any statistical analysis include the identification of suitable end points, the choice of measure to represent the distribution of the comet end point in a sample of cells, estimates of variability between experimental units and the identification of the size of effects that could be considered biologically important. Power and sample size calculations can be used in conjunction with this information to identify optimum experimental sizes and provide help in combining the results of statistical analyses with other information to aid interpretation. Interpretation based upon the size of effects and their confidence intervals is preferred to that based solely upon statistical significance tests. Statistical issues associated with the design and subsequent analyses of current validation studies for the comet assay include the identification of acceptable levels of intra- and inter-laboratory repeatability and reproducibility and criteria for dichotomizing results into positive or negative.</p>
]]></description>
<dc:creator><![CDATA[Lovell, D. P., Omori, T.]]></dc:creator>
<dc:date>2008-05-02</dc:date>
<dc:identifier>info:doi/10.1093/mutage/gen015</dc:identifier>
<dc:title><![CDATA[Statistical issues in the use of the comet assay]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>182</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>171</prism:startingPage>
<prism:section>REVIEWS</prism:section>
</item>

<item rdf:about="http://mutage.oxfordjournals.org/cgi/content/short/23/3/183?rss=1">
<title><![CDATA[Potential use of the comet assay in the clinical management of cancer]]></title>
<link>http://mutage.oxfordjournals.org/cgi/content/short/23/3/183?rss=1</link>
<description><![CDATA[
<p>The comet assay has been widely used to measure a range of cellular responses to DNA damage and has found applications in genotoxicity studies, bio-monitoring, ecological testing and in the study of human disease. This review discusses how the comet assay has been applied to the study of DNA damage and repair associated with cancer. The potential of the assay as a tool for predicting an individual's tumour sensitivity to radiation and to various chemotherapeutic drugs is examined, as well as outlining the usefulness of the assay in assessing oxidative stress within tumours. In addition, we review the use of the comet assay in investigations of the DNA-damaging effect of anti-neoplastic drugs and radiation used during cancer therapy. The advantages and limitations of the comet assay in carrying out all these studies are outlined, and the suitability of the comet assay for use in the clinical management of cancer is discussed.</p>
]]></description>
<dc:creator><![CDATA[McKenna, D. J., McKeown, S. R., McKelvey-Martin, V. J.]]></dc:creator>
<dc:date>2008-05-02</dc:date>
<dc:identifier>info:doi/10.1093/mutage/gem054</dc:identifier>
<dc:title><![CDATA[Potential use of the comet assay in the clinical management of cancer]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>190</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>183</prism:startingPage>
<prism:section>REVIEWS</prism:section>
</item>

<item rdf:about="http://mutage.oxfordjournals.org/cgi/content/short/23/3/191?rss=1">
<title><![CDATA[The comet assay in human biomonitoring: gene-environment interactions]]></title>
<link>http://mutage.oxfordjournals.org/cgi/content/short/23/3/191?rss=1</link>
<description><![CDATA[
<p>The comet assay is the method of choice for measuring DNA damage, of various sorts, in human cells such as lymphocytes obtained in the course of population-based studies of environmental and occupational exposure to different genotoxic agents, including radiation, chemicals and oxidative stress. It is noted for its versatility and the breadth of its possible applications. In terms of simplicity, cost, small amount of material required, sensitivity and reliability, the comet assay in its various modifications has few serious competitors. When standardized and validated, the comet assay can provide invaluable information in the areas of hazard identification and risk assessment of environmental and occupational exposure, diseases linked with oxidative stress (e.g. diabetes and cardiovascular disease), nutrition, monitoring the effectiveness of medical treatment and investigating individual variation in response to DNA damage that may reflect genetic or environmental influences. The information obtained could lead to individual advice on lifestyle changes to promote health and especially on relative risks of genotoxic exposure to environmental pollution.</p>
]]></description>
<dc:creator><![CDATA[Dusinska, M., Collins, A. R.]]></dc:creator>
<dc:date>2008-05-02</dc:date>
<dc:identifier>info:doi/10.1093/mutage/gen007</dc:identifier>
<dc:title><![CDATA[The comet assay in human biomonitoring: gene-environment interactions]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>205</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>191</prism:startingPage>
<prism:section>REVIEWS</prism:section>
</item>

<item rdf:about="http://mutage.oxfordjournals.org/cgi/content/short/23/3/207?rss=1">
<title><![CDATA[Ecotoxicological applications and significance of the comet assay]]></title>
<link>http://mutage.oxfordjournals.org/cgi/content/short/23/3/207?rss=1</link>
<description><![CDATA[
<p>Application of the single-cell gel electrophoresis or comet assay has revolutionized the field of genetic ecotoxicology or eco-genotoxicology. It is a rapid, sensitive and relatively inexpensive method providing the opportunity to study DNA damage (including oxidative damage), repair and cell death (apoptosis) in different cell types without prior knowledge of karyotype and cell turnover rate. The assay has, however, often attracted criticism for its lack of ecotoxicological relevance. In addition, in contrast to genetic toxicology where rapid technical progress has been made to improve cell- and tissue-specific adoption of the assay, only limited advancement has been made to transfer the methodologies to ecotoxicological studies. While reviewing the recent information available in the literature and underscoring the importance of induced genetic damage in natural species, the aims of this article are to (i) highlight and judiciously analyse the ecotoxicological relevance of the assay; (ii) attempt to correlate the comet response with other relevant biological responses or biomarkers; (iii) identify the technical challenges and various factors affecting its application in order to make it reliable, reproducible and robust; (iv) critically compare the technical developments in genetic toxicology and genetic ecotoxicology and (v) evaluate the future developments with respect to applications of the assay. It is suggested that while complementing other ecotoxicological parameters and further improving the methodologies, the comet assay will continue to play an important role in genetic ecotoxicology to determine induced genetic damage, which has significant consequences for short- and long-term survival of the natural or wild species. Information obtained through integrated studies using simultaneous applications of multiple biomarkers on different wild organisms could also provide an holistic dimension of toxicological impact of environmental contaminants for the protection of human health.</p>
]]></description>
<dc:creator><![CDATA[Jha, A. N.]]></dc:creator>
<dc:date>2008-05-02</dc:date>
<dc:identifier>info:doi/10.1093/mutage/gen014</dc:identifier>
<dc:title><![CDATA[Ecotoxicological applications and significance of the comet assay]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>221</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>207</prism:startingPage>
<prism:section>REVIEWS</prism:section>
</item>

<item rdf:about="http://mutage.oxfordjournals.org/cgi/content/short/23/3/223?rss=1">
<title><![CDATA[Variation in assessment of oxidatively damaged DNA in mononuclear blood cells by the comet assay with visual scoring]]></title>
<link>http://mutage.oxfordjournals.org/cgi/content/short/23/3/223?rss=1</link>
<description><![CDATA[
<p>The comet assay is popular for assessments of genotoxicity, but the comparison of results between studies is challenging because of differences in experimental procedures and reports of DNA damage in different units. We investigated the variation of DNA damage in mononuclear blood cells (MNBCs) measured by the comet assay with focus on the variation related to alkaline unwinding and electrophoresis time, number of cells scored, as well as the putative benefits of transforming the primary end points to common units by the use of reference standards and calibration curves. Eight experienced investigators scored pre-made slides of nuclei differently, but each investigator scored constantly over time. Scoring of 200 nuclei per treatment was associated with the lowest residual variation. Alkaline unwinding for 20 or 40 min and electrophoresis for 20 or 30 min yielded different dose&ndash;response relationships of cells exposed to -radiation and it was possible to reduce the variation in oxidized purines in MNBCs from humans by adjusting the level of lesions with protocol-specific calibration curves. However, there was a difference in the level of DNA damage measured by different investigators and this variation could not be reduced by use of investigator-specific calibration curves. The mean numbers of lesions per 10<sup>6</sup> bp in MNBCs from seven humans were 0.23 [95% confidence interval (CI): 0.14&ndash;0.33] and 0.31 (95% CI: 0.20&ndash;0.55) for strand breaks (SBs) and oxidized guanines, respectively. In conclusion, our results indicate that inter-investigator difference in scoring is a strong determinant of DNA damage levels measured by the comet assay.</p>
]]></description>
<dc:creator><![CDATA[Forchhammer, L., Brauner, E. V., Folkmann, J. K., Danielsen, P. H., Nielsen, C., Jensen, A., Loft, S., Friis, G., Moller, P.]]></dc:creator>
<dc:date>2008-05-02</dc:date>
<dc:identifier>info:doi/10.1093/mutage/gen006</dc:identifier>
<dc:title><![CDATA[Variation in assessment of oxidatively damaged DNA in mononuclear blood cells by the comet assay with visual scoring]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>231</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>223</prism:startingPage>
<prism:section>ORIGINAL PAPERS</prism:section>
</item>

<item rdf:about="http://mutage.oxfordjournals.org/cgi/content/short/23/3/233?rss=1">
<title><![CDATA[Recommendations for design of the rat comet assay]]></title>
<link>http://mutage.oxfordjournals.org/cgi/content/short/23/3/233?rss=1</link>
<description><![CDATA[
<p>Although the rodent comet assay is gaining acceptance as a standard technique for evaluating DNA damage <I>in vivo</I>, there is no internationally accepted guideline for its conduct and several aspects of its experimental design have not been optimized. For example, no standard positive control is used, there is no agreement on how tissue toxicity should be measured and sources of experimental variability have not been considered in relation to experimental design. This study showed that methylnitrosourea is a good alternative positive control inducing DNA damage in all tissues examined (stomach, liver, blood and bone marrow) over a dose range of 25&ndash;100 mg/kg at both 3 and 24 h after treatment. At the highest dose, significant toxicity was seen in all tissues using the neutral diffusion assay and also by histopathological/haematological analysis, except in the liver where no change was seen even 7 days after dosing. Analyses using control data pooled from several studies showed that, as expected, the greatest variability was seen between tissue preparations from different animals and that different numbers of animals were required to detect the same fold increases in different tissues. Power analyses showed that, preparing three gels for each tissue and scoring 50 nuclei per gel, a group of six animals allows 2-fold increases over control in the liver, bone marrow and stomach and a 3-fold increase in blood to be detected with 80% probability. It is recommended that similar investigations of experimental variability should be performed to determine optimal experimental design in any laboratory using the rodent comet assay.</p>
]]></description>
<dc:creator><![CDATA[Smith, C. C., Adkins, D. J., Martin, E. A., O'Donovan, M. R.]]></dc:creator>
<dc:date>2008-05-02</dc:date>
<dc:identifier>info:doi/10.1093/mutage/gen008</dc:identifier>
<dc:title><![CDATA[Recommendations for design of the rat comet assay]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>240</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>233</prism:startingPage>
<prism:section>ORIGINAL PAPERS</prism:section>
</item>

<item rdf:about="http://mutage.oxfordjournals.org/cgi/content/short/23/2/77?rss=1">
<title><![CDATA[Variability in cytogenetic adaptive response of cultured human lymphocytes to mitomycin C, bleomycin, quinacrine dihydrochloride, Co60 {gamma}-rays and hyperthermia]]></title>
<link>http://mutage.oxfordjournals.org/cgi/content/short/23/2/77?rss=1</link>
<description><![CDATA[
<p>Adaptive response (AR) is a well-documented phenomenon by which cells or organisms exposed to low dose of a genotoxicant become less sensitive to subsequent high-dose exposure to the same or another genotoxicant. AR, if induced can modify the efficacy leading to drug or radio-resistance, during anti-neoplastic drug or radiation treatment. Contradictions exist in AR induction by different genotoxicants with respect to the biomarkers, time schedules, and inter-individual variability, reflecting the complexity of AR in eukaryotic cells. In order to further ascertain these factors, AR induced by anti-neoplastic agents mitomycin C (MMC), bleomycin (BLM) and chemosterilant quinacrine dihydrochloride was examined in different donors and time schedules using cytogenetic biomarkers chromosome aberrations, sister chromatid exchanges and micronuclei (MN). BLM- and hyperthermia (HT)-induced cross-resistance to gamma rays and MMC/BLM, respectively, was also studied. Difference between MMC- and BLM-induced protective effects in biomarkers examined in the same donors was noticed. Adaptation to BLM and HT showed cross-resistance to chromosome damage induction by gamma rays and BLM/MMC, respectively. Cell cycle analysis indicated that adaptation is not caused by change in the rate of cell proliferation after challenge dose. MN as a chromosomal biomarker in large-scale population studies on AR is advocated, based on similar AR induced in all donors by MMC/BLM and rapid assessment in binucleated cells. Influence of certain genotypes on chromosomal biomarkers used in AR studies and role of AR in radiation and chemotherapy need to be further deciphered.</p>
]]></description>
<dc:creator><![CDATA[Krishnaja, A. P., Sharma, N. K.]]></dc:creator>
<dc:date>2008-03-03</dc:date>
<dc:identifier>info:doi/10.1093/mutage/gem045</dc:identifier>
<dc:title><![CDATA[Variability in cytogenetic adaptive response of cultured human lymphocytes to mitomycin C, bleomycin, quinacrine dihydrochloride, Co60 {gamma}-rays and hyperthermia]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>86</prism:endingPage>
<prism:publicationDate>2008-03-01</prism:publicationDate>
<prism:startingPage>77</prism:startingPage>
<prism:section>ORIGINAL PAPERS</prism:section>
</item>

<item rdf:about="http://mutage.oxfordjournals.org/cgi/content/short/23/2/87?rss=1">
<title><![CDATA[The frequency of CC to TT tandem mutations in mismatch repair-deficient cells is increased in a cytosine run]]></title>
<link>http://mutage.oxfordjournals.org/cgi/content/short/23/2/87?rss=1</link>
<description><![CDATA[
<p>Mononucleotide runs are hot spots for frameshift mutations in mismatch repair (MMR)-deficient cells. However, a role for mononucleotide runs in the formation of base pair substitutions has not been tested. Previously, we demonstrated that ultraviolet radiation C (UVC)- or reactive oxygen species-induced CC to TT tandem mutations are markedly enhanced in MMR-deficient cells. The target for the mutational analysis was two cytosines in a run of five cytosines (5C) within mouse <I>Aprt</I>. Because mutation from C to T for either or both of the two critical cytosines created a codon yielding a functional Aprt protein, this assay allowed both single and tandem substitutions to be quantified and the relative ratios compared. To determine if the cytosine run increased the frequency of single and/or tandem base pair substitutions, alternative constructs were created in which the cytosine run was disrupted by flanking the target cytosines with either thymines (2Cpyr) or adenines (2Cpur). Disruption of the cytosine run dramatically decreased the frequency of UVC-induced tandem mutations in the 2Cpyr and 2Cpur constructs, as compared with the 5C construct. Moreover, CC to TT tandem mutations occurred spontaneously or were induced by oxidative stress only within the 5C construct. These results demonstrate that CC to TT tandem mutations in MMR-deficient cells form more readily in a homocytosine run than in a sequence limited to two cytosines.</p>
]]></description>
<dc:creator><![CDATA[Skinner, A. M., Dan, C., Turker, M. S.]]></dc:creator>
<dc:date>2008-03-03</dc:date>
<dc:identifier>info:doi/10.1093/mutage/gem047</dc:identifier>
<dc:title><![CDATA[The frequency of CC to TT tandem mutations in mismatch repair-deficient cells is increased in a cytosine run]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>91</prism:endingPage>
<prism:publicationDate>2008-03-01</prism:publicationDate>
<prism:startingPage>87</prism:startingPage>
<prism:section>ORIGINAL PAPERS</prism:section>
</item>

<item rdf:about="http://mutage.oxfordjournals.org/cgi/content/short/23/2/93?rss=1">
<title><![CDATA[Antioxidant and anti-mutagenic effects of ebselen in yeast and in cultured mammalian V79 cells]]></title>
<link>http://mutage.oxfordjournals.org/cgi/content/short/23/2/93?rss=1</link>
<description><![CDATA[
<p>Ebselen has a wide spectrum of interesting therapeutic actions including antioxidant, cytoprotective, neuroprotective and anti-inflammatory activities. Since its antioxidant effect is very well known, this paper links the effects of ebselen in redox cellular status to its possible involvement in the maintenance of the integrity of genomic information by using <I>Saccharomyces cerevisiae</I> strains proficient and deficient in antioxidant defences and the mammalian V79 cell line. Using the alkaline comet assay, we showed that 5&ndash;10 &micro;M ebselen does not induce DNA damage in V79 cells. Similarly, these same concentrations diminished the extent of the DNA damage induced by hydrogen peroxide (H<SUB>2</SUB>O<SUB>2</SUB>). The modified comet assay using DNA glycosylases (formamidopyrimidine-DNA glycosylase and endonuclease II) showed that after pre-treatment with ebselen followed by exposure to H<SUB>2</SUB>O<SUB>2</SUB>, oxidative damage as recognized by these enzymes was significantly lower. In the same way, ebselen showed strong activity against H<SUB>2</SUB>O<SUB>2</SUB>-induced oxidative damage in the anti-mutagenic assay using <I>S.cerevisiae</I> N123 strain and in the antioxidative assay by using <I>S.cerevisiae</I> strains lacking antioxidant defences. This antioxidant effect was more pronounced for the <I>gpx3 </I> mutant, which indicated that ebselen acts by mimicking the GPx3 catalytic activity. The results confirm that ebselen is involved in antioxidant defence and that its antioxidant ability contributes to its anti-mutagenic and anti-genotoxic action.</p>
]]></description>
<dc:creator><![CDATA[Miorelli, S. T., Rosa, R. M., Moura, D. J., Rocha, J. C., Carneiro Lobo, L. A., Pegas Henriques, J. A., Saffi, J.]]></dc:creator>
<dc:date>2008-03-03</dc:date>
<dc:identifier>info:doi/10.1093/mutage/gem048</dc:identifier>
<dc:title><![CDATA[Antioxidant and anti-mutagenic effects of ebselen in yeast and in cultured mammalian V79 cells]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>99</prism:endingPage>
<prism:publicationDate>2008-03-01</prism:publicationDate>
<prism:startingPage>93</prism:startingPage>
<prism:section>ORIGINAL PAPERS</prism:section>
</item>

<item rdf:about="http://mutage.oxfordjournals.org/cgi/content/short/23/2/101?rss=1">
<title><![CDATA[Pre-irradiation exposure of peripheral blood lymphocytes to glutaraldehyde induces radiosensitization by increasing the initial yield of radiation-induced chromosomal aberrations]]></title>
<link>http://mutage.oxfordjournals.org/cgi/content/short/23/2/101?rss=1</link>
<description><![CDATA[
<p>Glutaraldehyde (GA) is a high production volume chemical that is very reactive with a wide spectrum of medical, scientific and industrial applications. Since human exposure in anthropogenic and occupational environment occurs frequently, GA has been extensively tested for genotoxic activity <I>in vitro</I> and <I>in vivo</I>. However, there are conflicting results in the literature and there is a lack of information concerning the combined effects of exposure to both GA and ionizing radiation in human cells. In the present study, the results obtained using conventional cytogenetic analysis do not suggest a statistically significant clastogenic or genotoxic activity of GA when concentrations in the range of 10<sup>&ndash;6</sup> to 10<sup>&ndash;2</sup> mM were applied. However, a 24-h pre-irradiation exposure of human peripheral blood lymphocytes (PBLs) to non-genotoxic doses of GA showed a statistically significant (<I>P</I> &gt; 0.05) increase in chromosomal radiosensitivity. The observed increase may be an effect of GA-induced alterations in the cell-cycle and feedback control mechanisms during the cell-cycle transition points or it may be a consequence of an effect of GA either on the DNA repair capacity of the cells after irradiation or on the initial induction of radiation-induced chromosomal damage. To elucidate the mechanism underlying the obtained radiosensitization, conventional cytogenetics, the G2 chromosomal radiosensitivity assay and premature chromosome condensation methodologies were applied. The results support the hypothesis that pre-irradiation exposure of PBLs to GA induces radiosensitization by increasing the initial yield of chromosomal aberrations following irradiation.</p>
]]></description>
<dc:creator><![CDATA[Hatzi, V. I., Terzoudi, G. I., Makropoulos, V., Maravelias, C., Pantelias, G. E.]]></dc:creator>
<dc:date>2008-03-03</dc:date>
<dc:identifier>info:doi/10.1093/mutage/gem049</dc:identifier>
<dc:title><![CDATA[Pre-irradiation exposure of peripheral blood lymphocytes to glutaraldehyde induces radiosensitization by increasing the initial yield of radiation-induced chromosomal aberrations]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>109</prism:endingPage>
<prism:publicationDate>2008-03-01</prism:publicationDate>
<prism:startingPage>101</prism:startingPage>
<prism:section>ORIGINAL PAPERS</prism:section>
</item>

<item rdf:about="http://mutage.oxfordjournals.org/cgi/content/short/23/2/111?rss=1">
<title><![CDATA[Cycloheximide and disulfoton are positive in the photoclastogencity assay but do not absorb UV irradiation: another example of pseudophotoclastogenicity?]]></title>
<link>http://mutage.oxfordjournals.org/cgi/content/short/23/2/111?rss=1</link>
<description><![CDATA[
<p>There is considerable concern regarding the biological plausibility of the response of certain chemicals in the <I>in vitro</I> photoclastogenicity assay, suggesting that this assay is oversensitive and lacks specificity. To explore this further, four coded compounds (aminotriazole, propantheline bromide, cycloheximide and disulfoton) were evaluated for their potential response in a photoclastogenicity assay in cultured Chinese hamster ovary (CHO) cells. None of the four compounds were shown to absorb ultraviolet radiation (UVR) or visible light in the 290- to 700-nm region of the electromagnetic spectrum. A fifth coded compound, tetracycline, which absorbs UVR, was also tested as this has previously been shown to be phototoxic <I>in vitro</I> (3T3-NRU assay) and is cytotoxic, but not genotoxic, at high concentrations in standard &lsquo;dark&rsquo; genotoxicity assays in mammalian cells. The results showed that cycloheximide, disulfoton and tetracycline were clastogenic in CHO cells following UVR exposure (solar-simulated light at 700 mJ/cm<sup>2</sup>) but not in the absence of UVR. Aminotriazole and propantheline were negative in the presence and absence of UVR exposure. Follow-up testing showed that neither cycloheximide nor disulfoton was positive in the 3T3-NRU assay, the standard <I>in vitro</I> regulatory test for phototoxicity, a result consistent with their inability to absorb UVR. These data suggest that both cycloheximide and disulfoton are pseudophotoclastogens, like zinc oxide. Together, these data question the specificity of the <I>in vitro</I> photoclastogencity assay in CHO cells and raises further concern regarding its use for the assessment of chemical photosafety for regulatory purposes. At the very least, a review of the current guidance documents for the photosafety evaluation of pharmaceuticals and cosmetics should be undertaken urgently.</p>
]]></description>
<dc:creator><![CDATA[Lynch, A. M., Robinson, S. A., Wilcox, P., Smith, M. D., Kleinman, M., Jiang, K., Rees, R. W.]]></dc:creator>
<dc:date>2008-03-03</dc:date>
<dc:identifier>info:doi/10.1093/mutage/gem053</dc:identifier>
<dc:title><![CDATA[Cycloheximide and disulfoton are positive in the photoclastogencity assay but do not absorb UV irradiation: another example of pseudophotoclastogenicity?]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>118</prism:endingPage>
<prism:publicationDate>2008-03-01</prism:publicationDate>
<prism:startingPage>111</prism:startingPage>
<prism:section>ORIGINAL PAPERS</prism:section>
</item>

<item rdf:about="http://mutage.oxfordjournals.org/cgi/content/short/23/2/119?rss=1">
<title><![CDATA[Involvement of homologous recombination repair after proton-induced DNA damage]]></title>
<link>http://mutage.oxfordjournals.org/cgi/content/short/23/2/119?rss=1</link>
<description><![CDATA[
<p>Protection from chronic exposure to cosmic radiation, which is primarily composed of protons, in future manned missions to Mars and beyond is considered to be a key unresolved issue. To model the effects of cosmic radiation on a living cell, we used <I>Saccharomyces cerevisiae</I> cells harboring various deletions of DNA repair genes to investigate the response of cells to DNA strand breaks caused by exposure to 250 MeV proton irradiation (linear energy transfer of 0.41 keV/&micro;m). In our study, DNA strand breaks induced by exposure to protons were predominantly repaired via the homologous recombination and postreplication repair pathways. We simulated chronic exposure to proton irradiation by treating cells from colonies that survived proton treatment, after several rounds of subculturing, to a second proton dose, as well as additional cell stressors. In general, cells cultured from proton surviving colonies were not more sensitive to secondary cell stressors. However, cells from <I>rad52</I> colonies that survived proton treatment showed increased resistance to secondary stressors, such as -rays (1.17 and 1.33 MeV; 0.267 keV/&micro;m), ultraviolet (UV) and proton irradiation and elevated temperatures. Resistance to secondary stressors was also observed in <I>rad52</I> cells that survived exposure to -rays, rather than protons, but this was not observed to occur in <I>rad52</I> cells after UV irradiation. <I>rad52</I> cells that survived exposure to protons, followed by -rays (proton surviving colonies were cultured prior to -ray exposure), exhibited an additive effect, whereby these cells had a further increase in stress resistance. A genetic analysis indicated that increased stress resistance is most likely due to a second-site mutation that suppresses the <I>rad52</I> phenotype. We will discuss possible origins of these second-site mutations.</p>
]]></description>
<dc:creator><![CDATA[Rostek, C., Turner, E. L., Robbins, M., Rightnar, S., Xiao, W., Obenaus, A., Harkness, T. A. A.]]></dc:creator>
<dc:date>2008-03-03</dc:date>
<dc:identifier>info:doi/10.1093/mutage/gem055</dc:identifier>
<dc:title><![CDATA[Involvement of homologous recombination repair after proton-induced DNA damage]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>129</prism:endingPage>
<prism:publicationDate>2008-03-01</prism:publicationDate>
<prism:startingPage>119</prism:startingPage>
<prism:section>ORIGINAL PAPERS</prism:section>
</item>

<item rdf:about="http://mutage.oxfordjournals.org/cgi/content/short/23/2/131?rss=1">
<title><![CDATA[p53-dependent global nucleotide excision repair of cisplatin-induced intrastrand cross links in human cells]]></title>
<link>http://mutage.oxfordjournals.org/cgi/content/short/23/2/131?rss=1</link>
<description><![CDATA[
<p>Cisplatin is an extremely effective chemotherapeutic agent used for the treatment of testicular and other solid tumours. It induces a variety of structural modifications in DNA, the most abundant being the GpG- and ApG-1,2-intrastrand cross links formed between adjacent purine bases. These cross links account for ~90% of cisplatin-induced DNA damage and are thought to be responsible for the cytotoxic activity of the drug. In human cells, the nucleotide excision repair (NER) process removes the intrastrand cross links from the genome, the efficiency of which is likely to be an important determinant of cisplatin cytotoxicity. We have investigated whether the p53 tumour suppressor status affects global NER of cisplatin-induced intrastrand cross links in human cells. We have used a <sup>32</sup>P-postlabelling method to monitor the removal of GpG- and ApG-intrastrand cross links from two human cell models (the 041TR system, in which p53 is regulated by a tetracycline-inducible promoter, together with WI38 fibroblasts and the SV40-transformed derivative VA13) that each differ in p53 status. We demonstrate that the absence of functional p53 leads to persistence of both cisplatin-induced intrastrand cross links in the genome, suggesting that p53 regulates NER of these DNA lesions. This observation extends the role of p53 in NER beyond enhancing the removal of environmentally induced DNA lesions to include those of clinical origin. Given the frequency of p53 mutations in human tumours, these results may have implications for the use of cisplatin in cancer chemotherapy.</p>
]]></description>
<dc:creator><![CDATA[Bhana, S., Hewer, A., Phillips, D. H., Lloyd, D. R.]]></dc:creator>
<dc:date>2008-03-03</dc:date>
<dc:identifier>info:doi/10.1093/mutage/gen001</dc:identifier>
<dc:title><![CDATA[p53-dependent global nucleotide excision repair of cisplatin-induced intrastrand cross links in human cells]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>136</prism:endingPage>
<prism:publicationDate>2008-03-01</prism:publicationDate>
<prism:startingPage>131</prism:startingPage>
<prism:section>ORIGINAL PAPERS</prism:section>
</item>

<item rdf:about="http://mutage.oxfordjournals.org/cgi/content/short/23/2/137?rss=1">
<title><![CDATA[Tandem duplication/triplication correlated with poly-cytosine stretch variation in human mitochondrial DNA D-loop region]]></title>
<link>http://mutage.oxfordjournals.org/cgi/content/short/23/2/137?rss=1</link>
<description><![CDATA[
<p>Somatic mutations in the mitochondrial DNA (mtDNA) displacement loop (D-loop) region have been frequently detected in various human cancers. In a previous study, we identified a polyplasmic 260-bp tandem duplication and triplication mutation in the mtDNA D-loop of one gastric cancer. In the present study, we adopted a more sensitive back-to-back polymerase chain reaction method to screen for this 260-bp tandem duplication/triplication in 197 cancers and their adjacent non-cancerous tissues. Nine samples of primary cancer (4.6%) were found to harbor the tandem duplication/triplication and these were made up of four out of 31 (12.9%) gastric cancers, two out of 45 (4.4%) breast cancers, two out of 56 (3.6%) hepatocellular cancers and one out of 32 (3.1%) colon cancers, but no tandem duplication/triplication was present in any of 33 lung cancers. We also found an expanded and polyplasmic poly-cytosine (poly-C) stretch around nucleotide position (np) 568 in eight of the 197 (4.1%) cancer patients. All the eight cancer samples carried the 260-bp tandem duplication/triplication. In addition, we detected the np 568 poly-C length variations in 11 of 234 (4.7%) peripheral blood samples of non-cancer population and the 260-bp tandem duplication in nine of the 11 cases with the np 568 poly-C length variations. These observations suggest that the occurrence of the tandem duplication/triplication in mtDNA D-loop is not specific for cancer tissues, but highly associated with the poly-C length variations around np 568.</p>
]]></description>
<dc:creator><![CDATA[Hung, W.-Y., Lin, J.-C., Lee, L.-M., Wu, C.-W., Tseng, L.-M., Yin, P.-H., Chi, C.-W., Lee, H.-C.]]></dc:creator>
<dc:date>2008-03-03</dc:date>
<dc:identifier>info:doi/10.1093/mutage/gen002</dc:identifier>
<dc:title><![CDATA[Tandem duplication/triplication correlated with poly-cytosine stretch variation in human mitochondrial DNA D-loop region]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>142</prism:endingPage>
<prism:publicationDate>2008-03-01</prism:publicationDate>
<prism:startingPage>137</prism:startingPage>
<prism:section>ORIGINAL PAPERS</prism:section>
</item>

<item rdf:about="http://mutage.oxfordjournals.org/cgi/content/short/23/1/1?rss=1">
<title><![CDATA[Correlation between biomarkers of human exposure to genotoxins with focus on carcinogen-DNA adducts]]></title>
<link>http://mutage.oxfordjournals.org/cgi/content/short/23/1/1?rss=1</link>
<description><![CDATA[
<p>Correlations among biomarkers, an important issue in biomarker research, provide enhanced insight and understanding of the complexity of molecular mechanisms initiated by environmental genotoxic agents in the human organism. Occupational and environmental exposures mostly represent mixtures of genotoxic agents, whereas the specificity of biomarker measurements varies widely. Here, we give an overview of the correlation studies with particular emphasis on DNA adduct biomarker analysis of exposure to polycyclic aromatic hydrocarbons (PAHs) and/or tobacco smoke. We have collected data on correlations between different DNA adduct detection methods, DNA adduct structures and DNA adduct levels in human tissues. Data are also presented on the correlation between DNA adducts and other biomarkers of exposure and of early biological effects, including protein adducts, urinary metabolites and cytogenetic end points. In numerous studies, <sup>32</sup>P-postlabelling and immunoassay measurements of DNA adducts recognized the difference between exposure groups similarly; however, at the individual level, there was, in general, not a statistically significant correlation between the two determinations. Inconsistency was found regarding the correlation between the levels of total bulky adducts and specific single DNA adduct structures. A number of studies found a positive correlation between DNA adduct levels in target and surrogate tissues, although stratification for exposure level may have influenced the results. Characteristically, there was a positive correlation between DNA adduct levels in tumour and normal tissue pairs. In general, there was a lack of correlation between DNA adducts and urinary PAH metabolites, but after stratification for particular genetic polymorphisms correlation may have emerged between the two biomarkers of exposure. The correlations with cytogenetic biomarkers were very complex, with examples of both positive correlation and lack of correlation. Exploration of correlations among biomarkers contributes to the further progress of molecular cancer epidemiology and to the selection of the optimal biomarkers for the investigation of human exposure to carcinogens.</p>
]]></description>
<dc:creator><![CDATA[Gyorffy, E., Anna, L., Kovacs, K., Rudnai, P., Schoket, B.]]></dc:creator>
<dc:date>2008-01-21</dc:date>
<dc:identifier>info:doi/10.1093/mutage/gem043</dc:identifier>
<dc:title><![CDATA[Correlation between biomarkers of human exposure to genotoxins with focus on carcinogen-DNA adducts]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>18</prism:endingPage>
<prism:publicationDate>2008-01-01</prism:publicationDate>
<prism:startingPage>1</prism:startingPage>
<prism:section>REVIEWS</prism:section>
</item>

<item rdf:about="http://mutage.oxfordjournals.org/cgi/content/short/23/1/19?rss=1">
<title><![CDATA[Fast repair of oxidative DNA damage by phenylpropanoid glycosides and their analogues]]></title>
<link>http://mutage.oxfordjournals.org/cgi/content/short/23/1/19?rss=1</link>
<description><![CDATA[
<p>The repair activities and reaction mechanisms of phenylpropanoid glycosides (PPGs) and their analogues, isolated from Chinese folk medicinal herbs, towards oxidative DNA damage were studied with pulse radiolytic technique. On pulse irradiation of nitrogen-saturated 4 mM poly C aqueous solution containing one of the tested polyphenols, 40 mM K<SUB>2</SUB>S<SUB>2</SUB>O<SUB>8</SUB> and 200 mM <I>t</I>-BuOH, the transient absorption spectrum of the oxidative radical of poly C decays with the concurrent formation of the phenoxyl radical of the tested polyphenols within several tens of microseconds after the electron pulse irradiation. The result indicated that there was a repair reaction between oxidative radical of poly C and the tested polyphenols. The repair activities also were observed for the tested polyphenols towards the radical cations of single-stranded DNA (ssDNA) and double-stranded DNA (dsDNA). The rate constants were determined to be 3.7&ndash;6.4 <FONT FACE="arial,helvetica">x</FONT> 10<sup>9</sup>, 4.8&ndash;5.5 <FONT FACE="arial,helvetica">x</FONT> 10<sup>8</sup> and 8.8&ndash;10.3 <FONT FACE="arial,helvetica">x</FONT> 10<sup>8</sup> M<sup>&ndash;1</sup>&middot;sec<sup>&ndash;1</sup> for the repair reactions of oxidative radical of poly C and radical cations of ssDNA and dsDNA, respectively. The result of this study together with those of our previous studies demonstrates that PPGs and their analogues can fast repair not only the damage of deoxynucleoside and deoxynucleotide but also the damage of integral DNA, with the latter being closer to a cellular condition.</p>
]]></description>
<dc:creator><![CDATA[Shi, Y., Wang, W., Huang, C., Jia, Z., Yao, S., Zheng, R.]]></dc:creator>
<dc:date>2008-01-21</dc:date>
<dc:identifier>info:doi/10.1093/mutage/gem028</dc:identifier>
<dc:title><![CDATA[Fast repair of oxidative DNA damage by phenylpropanoid glycosides and their analogues]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>26</prism:endingPage>
<prism:publicationDate>2008-01-01</prism:publicationDate>
<prism:startingPage>19</prism:startingPage>
<prism:section>ORIGINAL PAPERS</prism:section>
</item>

<item rdf:about="http://mutage.oxfordjournals.org/cgi/content/short/23/1/27?rss=1">
<title><![CDATA[Assessment of the genotoxicity of trichloroethylene and its metabolite, S-(1,2-dichlorovinyl)-L-cysteine (DCVC), in the comet assay in rat kidney]]></title>
<link>http://mutage.oxfordjournals.org/cgi/content/short/23/1/27?rss=1</link>
<description><![CDATA[
<p>Trichloroethylene (TCE) has been reported to give a small, but significant, increase in renal tumours in the rat. These tumours were always associated with nephrotoxicity which is most likely caused by the metabolism of TCE to S-(1,2-dichlorovinyl)-<scp>L</scp>-cysteine (DCVC) which accumulates in the proximal tubules. The genotoxicity of TCE and DCVC have been evaluated <I>in vivo</I> using the comet assay to assess DNA breakage in the proximal tubules of rat kidneys. Rats were exposed to TCE by inhalation or to DCVC by oral gavage at dose levels in excess of those which produced effects in long-term bioassays. Cell suspensions were produced from proximal tubules isolated from the kidneys of treated rats and the level of DNA damage assessed in these cells using the pH &gt;13 comet assay. <I>In vitro</I> and <I>in vivo</I> positive controls were included and demonstrated the sensitivity of the assay. TCE gave a clearly negative response in the assay at all dose levels as did DCVC at the 16-h sampling time and at the 2-h sampling time with the lower dose level. At the 2-h sampling time following administration of DCVC at the higher dose level (10 mg/kg), there was limited evidence of DNA damage in a small number of animals, but this was considered insufficient to indicate a positive response in this assay. These data support an overall conclusion, based on these and other published data, that the renal tumours seen in bioassays are non-genotoxic in origin.</p>
]]></description>
<dc:creator><![CDATA[Clay, P.]]></dc:creator>
<dc:date>2008-01-21</dc:date>
<dc:identifier>info:doi/10.1093/mutage/gem034</dc:identifier>
<dc:title><![CDATA[Assessment of the genotoxicity of trichloroethylene and its metabolite, S-(1,2-dichlorovinyl)-L-cysteine (DCVC), in the comet assay in rat kidney]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>33</prism:endingPage>
<prism:publicationDate>2008-01-01</prism:publicationDate>
<prism:startingPage>27</prism:startingPage>
<prism:section>ORIGINAL PAPERS</prism:section>
</item>

<item rdf:about="http://mutage.oxfordjournals.org/cgi/content/short/23/1/35?rss=1">
<title><![CDATA[hOGG1326, XRCC1399 and XRCC3241 polymorphisms influence micronucleus frequencies in human lymphocytes in vivo]]></title>
<link>http://mutage.oxfordjournals.org/cgi/content/short/23/1/35?rss=1</link>
<description><![CDATA[
<p>A pooled analysis of five biomonitoring studies was performed to assess the influence of <I>hOGG1<sup>326</sup></I>, <I>XRCC1<sup>399</sup></I> and <I>XRCC3<sup>241</sup></I> gene polymorphisms on micronuclei (MN) frequency in human peripheral blood lymphocytes, as measured by the <I>ex vivo/in vitro</I> cytokinesis-block micronucleus (CBMN) assay. Each study addressed a type of occupational exposure potentially able to induce DNA strand breakage (styrene, ionising radiation, cobalt/hard metal, welding fumes and inorganic arsenite compounds), and therefore MN, as a result of base excision repair and double-strand break repair deficiencies. The effect of genotype, age, exposure to genotoxic agents and smoking habit on MN induction was determined using Poisson regression analysis in 171 occupationally exposed male workers and in 132 non-exposed male referents. The analysis of genotype&ndash;genotype, genotype&ndash;smoking and genotype&ndash;exposure interactions by linear combinations of parameters showed significantly higher MN frequencies in the following subsets: (i) occupationally exposed workers carrying either the Thr/Thr or the Thr/Met <I>XRCC3<sup>241</sup></I> genotypes compared to their referent counterparts (<I>P</I> &lt; 0.001) and (ii) carriers of the Met/Met <I>XRCC3<sup>241</sup></I> genotype compared to Thr/Thr <I>XRCC3<sup>241</sup></I> carriers, as far as they are non-exposed and bear the variant (Ser/Cys or Cys/Cys) <I>hOGG1<sup>326</sup></I> genotype (<I>P</I> &lt; 0.01). Significantly lower MN frequencies were observed in carriers of the variant <I>hOGG1<sup>326</sup></I> genotype compared to Ser/Ser <I>hOGG1<sup>326</sup></I> carriers in the subgroup of non-smokers with Thr/Thr <I>XRCC3<sup>241</sup></I> genotype (<I>P</I> &lt; 0.01). Stratified analysis by occupational exposure showed a significant MN increase with smoking in occupationally exposed carriers of the Arg/Gln <I>XRCC1<sup>399</sup></I>genotype (<I>P</I> &lt; 0.001). In contrast, a significant MN decrease with smoking was observed in referents carrying the Ser/Ser <I>hOGG1<sup>326</sup></I> genotype (<I>P</I> &lt; 0.01). These findings provide evidence that the combination of different DNA repair genes and their interaction with environmental genotoxic agents may modulate MN induction. Understanding the complexity of the relationships between exposure, DNA repair and MN frequencies require larger scale studies and complementary biomarkers.</p>
]]></description>
<dc:creator><![CDATA[Mateuca, R. A., Roelants, M., Iarmarcovai, G., Aka, P. V., Godderis, L., Tremp, A., Bonassi, S., Fenech, M., Berge-Lefranc, J.-L., Kirsch-Volders, M.]]></dc:creator>
<dc:date>2008-01-21</dc:date>
<dc:identifier>info:doi/10.1093/mutage/gem040</dc:identifier>
<dc:title><![CDATA[hOGG1326, XRCC1399 and XRCC3241 polymorphisms influence micronucleus frequencies in human lymphocytes in vivo]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>41</prism:endingPage>
<prism:publicationDate>2008-01-01</prism:publicationDate>
<prism:startingPage>35</prism:startingPage>
<prism:section>ORIGINAL PAPERS</prism:section>
</item>

<item rdf:about="http://mutage.oxfordjournals.org/cgi/content/short/23/1/43?rss=1">
<title><![CDATA[The role of p53 in DNA damage-mediated cytotoxicity overrides its ability to regulate nucleotide excision repair in human fibroblasts]]></title>
<link>http://mutage.oxfordjournals.org/cgi/content/short/23/1/43?rss=1</link>
<description><![CDATA[
<p>The p53 tumour suppressor protein plays a pivotal role in the response of mammalian cells to DNA damage. In addition to its regulatory role in cell cycle progression, p53 regulates apoptosis and can therefore influence cellular survival in response to DNA damage. More recent work has revealed that p53 is also involved in the nucleotide excision repair (NER) of structurally diverse types of DNA damage. The relative influence of p53 on NER and cellular sensitivity to DNA damage was investigated in this study using cells that differ in p53 status. Two cell models were selected: 041 TR fibroblasts in which the expression of p53 is regulated by a tetracycline-inducible promoter, and WI38 primary lung fibroblasts together with their isogenic derivative VA13, in which p53 is abrogated post-translationally by SV40 transformation. Cells were exposed to the clinically and environmentally relevant DNA-damaging agents cisplatin (0&ndash;5 &micro;M, 2 h), (&plusmn;)-<I>anti</I>-benzo(<I>a</I>)pyrene-7,8-dihydrodiol-9,10-epoxide (0&ndash;0.5 &micro;M, 30 min) and UV-C (0&ndash;5 J/m<sup>2</sup>), each of which induce structurally distinct types of DNA damage known to be subject to p53-dependent NER. Sensitivity of the p53-proficient and p53-deficient cells to this DNA damage was then compared at each dose of DNA-damaging agent using the clonogenic survival assay and the colorimetric MTT assay. p53-proficient cells were more sensitive than p53-deficient cells to cisplatin, (&plusmn;)-<I>anti</I>-benzo(a)pyrene-7,8-dihydrodiol-9,10-epoxide and UV-C; these differences in cellular sensitivity were more apparent in the 041 TR cells (up to 3.6-, 5.8- and 1.9-fold, respectively) than the WI38/VA13 cells (up to 2.3-, 1.4- and 1.4-fold, respectively). Thus, despite the well-documented persistence of DNA damage in p53-deficient fibroblasts due to impaired NER, loss of p53 results in reduced DNA damage-mediated cytotoxicity.</p>
]]></description>
<dc:creator><![CDATA[Bhana, S., Lloyd, D. R.]]></dc:creator>
<dc:date>2008-01-21</dc:date>
<dc:identifier>info:doi/10.1093/mutage/gem041</dc:identifier>
<dc:title><![CDATA[The role of p53 in DNA damage-mediated cytotoxicity overrides its ability to regulate nucleotide excision repair in human fibroblasts]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>50</prism:endingPage>
<prism:publicationDate>2008-01-01</prism:publicationDate>
<prism:startingPage>43</prism:startingPage>
<prism:section>ORIGINAL PAPERS</prism:section>
</item>

<item rdf:about="http://mutage.oxfordjournals.org/cgi/content/short/23/1/51?rss=1">
<title><![CDATA[DNA repair deficiency and acetaldehyde-induced chromosomal alterations in CHO cells]]></title>
<link>http://mutage.oxfordjournals.org/cgi/content/short/23/1/51?rss=1</link>
<description><![CDATA[
<p>Induction of chromosomal aberrations (CAs) and sister chromatid exchanges (SCEs) by acetaldehyde (AA) was evaluated in parental and different DNA repair-deficient Chinese hamster ovary (CHO) cell lines to elucidate the mechanisms involved in the protection against AA-induced chromosome damage. Cell lines employed included the parental (AA8), nucleotide excision repair (UV4, UV5, UV61), base excision repair (EM9), homologous recombination repair (HRR) (irs1SF, 51D1)-deficient and Fanconi-like (KO40) ones. The ranking of different cell lines for sensitivity to induction of CAs by AA was 51D1 &gt; irs1SF &gt; KO40 &gt; UV4 &gt; V33-EM9-AA8 &gt; UV61-UV5 in a descending order. Cells deficient in HRR were most sensitive followed by Fanconi anaemia like (KO40) suggesting these pathways, especially HRR is very important for the repair of AA-induced lesions. These observations also suggest that interstrand cross links are primary biologically relevant DNA lesions induced by AA for induction of CAs. Only marginal differences were found between the cell lines for induction of SCEs. The possible mechanisms involved in AA-induced chromosomal alterations are discussed.</p>
]]></description>
<dc:creator><![CDATA[Mechilli, M., Schinoppi, A., Kobos, K., Natarajan, A. T., Palitti, F.]]></dc:creator>
<dc:date>2008-01-21</dc:date>
<dc:identifier>info:doi/10.1093/mutage/gem042</dc:identifier>
<dc:title><![CDATA[DNA repair deficiency and acetaldehyde-induced chromosomal alterations in CHO cells]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>56</prism:endingPage>
<prism:publicationDate>2008-01-01</prism:publicationDate>
<prism:startingPage>51</prism:startingPage>
<prism:section>ORIGINAL PAPERS</prism:section>
</item>

<item rdf:about="http://mutage.oxfordjournals.org/cgi/content/short/23/1/57?rss=1">
<title><![CDATA[Chromosome 17 and 21 aneuploidy in buccal cells is increased with ageing and in Alzheimer's disease]]></title>
<link>http://mutage.oxfordjournals.org/cgi/content/short/23/1/57?rss=1</link>
<description><![CDATA[
<p>Alzheimer's disease (AD) is a premature ageing syndrome characterized by cognitive impairment arising from neuropathological changes occurring within specific areas of the brain. We report a 1.5-fold increase in trisomy 21 (<I>P</I> &lt; 0.001) and a 1.2-fold increase in trisomy 17 (<I>P</I> &lt; 0.001) in buccal cells of Alzheimer's patients compared to age- and gender-matched controls. Chromosome 17 and chromosome 21 monosomy and trisomy increase significantly with age (<I>P</I> &lt; 0.001). Down's syndrome, which exhibits similar neuropathological features to those observed in AD also showed a strong increase in chromosome 17 monosomy and trisomy compared to matched controls (<I>P</I> &lt; 0.001). These results suggest that an increased incidence of aneusomy for both chromosomes 17 and 21 may contribute to the aetiology of AD. We also investigated aneuploidy rates in hippocampal brain cells, which have been shown to have a low rate of cell division, which may be relevant in potential incidence of non-disjunction. However, aneuploidy rate for chromosomes 17 and 21 in the nuclei of hippocampus cells of brains from Alzheimer's patients and controls were not significantly different. These results are suggestive that the aneuploidy events investigated which are increased beyond the incidence in normal ageing may be influenced by genetic factors that may predispose to AD, but are unlikely to be a primary cause of AD brain pathology.</p>
]]></description>
<dc:creator><![CDATA[Thomas, P., Fenech, M.]]></dc:creator>
<dc:date>2008-01-21</dc:date>
<dc:identifier>info:doi/10.1093/mutage/gem044</dc:identifier>
<dc:title><![CDATA[Chromosome 17 and 21 aneuploidy in buccal cells is increased with ageing and in Alzheimer's disease]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>65</prism:endingPage>
<prism:publicationDate>2008-01-01</prism:publicationDate>
<prism:startingPage>57</prism:startingPage>
<prism:section>ORIGINAL PAPERS</prism:section>
</item>

<item rdf:about="http://mutage.oxfordjournals.org/cgi/content/short/23/1/67?rss=1">
<title><![CDATA[Influence of TCDD and natural Ah receptor agonists on benzo[a]pyrene-DNA adduct formation in the Caco-2 human colon cell line]]></title>
<link>http://mutage.oxfordjournals.org/cgi/content/short/23/1/67?rss=1</link>
<description><![CDATA[
<p>Several compounds originating from cruciferous vegetables and citrus fruits bind to and activate the aryl hydrocarbon receptor (AhR). This receptor plays an important role in the toxicity of the known tumour promoter and potent AhR-agonist 2,3,7,8-tetrachlorodibenzo-<I>p</I>-dioxin (TCDD). However, vegetables and fruits are generally considered as healthy. Therefore, besides the AhR activation, the natural AhR agonists (NAhRAs) are assumed to show other health-concerning effects. AhR activation induces several cytochrome P450 phase I enzymes involved, e.g. in the bioactivation of carcinogenic polycyclic aromatic hydrocarbons, like benzo[<I>a</I>]pyrene (BaP), and may as such stimulate DNA adduct formation of those compounds. Therefore, the influence of TCDD, indolo[3,2-<I>b</I>]carbazole (ICZ, an NAhRA originating from cruciferous vegetables) and an NAhRA-containing extract of grapefruit juice (GJE) on BaP&ndash;DNA adduct formation in the human Caco-2 cell line was studied. Also, we investigated if different effects of TCDD, ICZ and GJE on adduct formation could be related to the modulation of transcription of biotransformation- and DNA-repair enzymes. Co-exposure to high AhR-activating concentrations of both TCDD and ICZ significantly reduced the amount of BaP&ndash;DNA adducts at 0.1 &micro;M BaP, while at higher concentrations of BaP no influence was observed. In contrast, exposure to 0.1 &micro;M BaP combined with GJE showed a significant increase in BaP&ndash;DNA adducts, and a significant decrease at 0.3 and 1 &micro;M BaP. These differences could not be related to transcription of the phase I and II enzymes CYP1A1, CYP1B1, NQO1, GSTP1 and UGT1A6 or to transcription of the nucleotide excision repair enzymes ERCC1, XPA, XPC, XPF and XPG. We conclude that ICZ showed a similar effect on BaP&ndash;DNA adduct formation than TCDD, while GJE influenced the adduct formation in a different way. The difference in the influence on adduct formation may be due to effects at the level of enzyme activity, rather than gene expression.</p>
]]></description>
<dc:creator><![CDATA[de Waard, P. W. J., de Kok, T. M. C. M., Maas, L. M., Peijnenburg, A. A. C. M., Hoogenboom, R. L. A. P., Aarts, J. M. M. J. G., van Schooten, F.-J.]]></dc:creator>
<dc:date>2008-01-21</dc:date>
<dc:identifier>info:doi/10.1093/mutage/gem046</dc:identifier>
<dc:title><![CDATA[Influence of TCDD and natural Ah receptor agonists on benzo[a]pyrene-DNA adduct formation in the Caco-2 human colon cell line]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>73</prism:endingPage>
<prism:publicationDate>2008-01-01</prism:publicationDate>
<prism:startingPage>67</prism:startingPage>
<prism:section>ORIGINAL PAPERS</prism:section>
</item>

<item rdf:about="http://mutage.oxfordjournals.org/cgi/content/short/23/1/75?rss=1">
<title><![CDATA[Editors' Note]]></title>
<link>http://mutage.oxfordjournals.org/cgi/content/short/23/1/75?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>2008-01-21</dc:date>
<dc:identifier>info:doi/10.1093/mutage/gem050</dc:identifier>
<dc:title><![CDATA[Editors' Note]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>23</prism:volume>
<prism:endingPage>75</prism:endingPage>
<prism:publicationDate>2008-01-01</prism:publicationDate>
<prism:startingPage>75</prism:startingPage>
<prism:section>Editors' Note</prism:section>
</item>

</rdf:RDF>